Form 8-K - Current report:
SEC Accession No. 0001178879-18-000013
Filing Date
2018-08-13
Accepted
2018-08-13 06:31:06
Documents
15
Period of Report
2018-08-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kxconferencecall.htm 8-K 20821
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 13204
3 amicuslogojuly2018a02.jpg GRAPHIC 127191
4 exhibit991001.jpg GRAPHIC 149962
5 exhibit991002.jpg GRAPHIC 240288
6 exhibit991003.jpg GRAPHIC 149139
7 exhibit991004.jpg GRAPHIC 158642
8 exhibit991005.jpg GRAPHIC 169850
9 exhibit991006.jpg GRAPHIC 163371
10 exhibit991007.jpg GRAPHIC 135287
11 exhibit991008.jpg GRAPHIC 166885
12 exhibit991009.jpg GRAPHIC 175965
13 exhibit991010.jpg GRAPHIC 165118
14 exhibit991011.jpg GRAPHIC 234990
15 exhibit991012.jpg GRAPHIC 71981
  Complete submission text file 0001178879-18-000013.txt   2932294
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 181010220
SIC: 2834 Pharmaceutical Preparations